DYADIC INTERNATIONAL INC (DYAI) Stock News

NASDAQ:DYAI - Nasdaq - US26745T1016 - Common Stock - Currency: USD

0.86 +0.05 (+6.17%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

DYAI Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Chartmill - Mentions: ALGN VAL FORM MDXG ...

News Image

Wednesday's after hours session: top gainers and losers

7 days ago - By: Dyadic International, Inc.

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

7 days ago - By: Dyadic International, Inc.

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

12 days ago - By: Dyadic International, Inc.

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

12 days ago - By: Dyadic International, Inc.

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

12 days ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

12 days ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

13 days ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

13 days ago - By: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

a month ago - By: Dyadic Applied BioSolutions

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

2 months ago - By: Dyadic International, Inc.

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

2 months ago - By: Dyadic International, Inc.

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

3 months ago - By: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

3 months ago - By: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

4 months ago - By: Dyadic International, Inc.

Dyadic to Present at World Vaccine Congress | Washington

4 months ago - By: Dyadic International, Inc.

Dyadic to Present at World Vaccine Congress | Washington

5 months ago - By: Dyadic International, Inc.

Dyadic Reports 2024 Year-End Financial Results and Business Updates

5 months ago - By: Dyadic International, Inc.

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

5 months ago - By: Dyadic International, Inc.

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

5 months ago - By: Dyadic International, Inc.

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

5 months ago - By: Dyadic International, Inc.

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

5 months ago - By: Dyadic International, Inc.

Dyadic to Attend Multiple Industry Events in March

5 months ago - By: Dyadic International, Inc.

Dyadic to Attend Multiple Industry Events in March

7 months ago - By: Dyadic International, Inc.

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

7 months ago - By: Dyadic International, Inc.

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

9 months ago - By: Dyadic International, Inc.

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

9 months ago - By: Dyadic International, Inc.

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

9 months ago - By: Benzinga - Mentions: SILV SKYX XTNT HNRG ...

Earnings Scheduled For November 12, 2024

9 months ago - By: Benzinga

Exploring Dyadic International's Earnings Expectations

9 months ago - By: Dyadic International, Inc.

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

9 months ago - By: Dyadic International, Inc.

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024